Valuation: Takara Bio Inc.

Capitalization 101B 635M 547M 509M 474M 882M 57.33B 946M 5.85B 2.3B 27.41B 2.38B 2.33B P/E ratio 2026 *
-19.9x
P/E ratio 2027 * 162x
Enterprise value 101B 635M 547M 509M 474M 882M 57.33B 946M 5.85B 2.3B 27.41B 2.38B 2.33B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.11x
Free-Float
38.39%
Yield 2026 *
-
Yield 2027 * 1.64%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.08%
1 week+0.49%
Current month+3.90%
1 month+4.96%
3 months-14.40%
6 months+0.98%
Current year+3.90%
More quotes
1 week 812
Extreme 812
836
1 month 761
Extreme 761
836
Current year 785
Extreme 785
836
1 year 711
Extreme 711
1,058
3 years 711
Extreme 711
1,826
5 years 711
Extreme 711
3,350
10 years 711
Extreme 711
3,535
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 -
Director of Finance/CFO 70 2019-12-31
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 63 2025-06-23
Director/Board Member 62 2018-05-31
Director/Board Member 65 2014-05-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.08%+0.49%-16.82%-50.45% 622M
+1.11%+2.66%+4.99%+15.10% 49.05B
-0.03%-1.23%+21.88%+8.62% 41.1B
-2.44%+1.32%+68.31%+24.99% 38.37B
-0.47%-0.24%+18.66%+36.02% 31.59B
+1.69%+20.02%+209.49%+309.67% 23.43B
+0.26%+0.81%+86.77%+170.41% 17.36B
-14.53%-43.15%+23,402.74%+3,721.51% 17.39B
+0.64%+5.01%+57.25%+12.41% 14.83B
-1.20%-10.03%-8.83%-18.68% 14.11B
Average -1.60%-1.87%+2,384.44%+422.96% 24.79B
Weighted average by Cap. -1.10%-0.54%+1,688.38%+314.76%
See all sector performances

Financials

2026 *2027 *
Net sales 44.38B 280M 241M 225M 209M 389M 25.3B 417M 2.58B 1.02B 12.1B 1.05B 1.03B 47.56B 300M 259M 241M 224M 417M 27.12B 447M 2.77B 1.09B 12.96B 1.13B 1.1B
Net income -5.06B -31.94M -27.52M -25.64M -23.86M -44.38M -2.89B -47.61M -295M -116M -1.38B -120M -117M 619M 3.91M 3.36M 3.14M 2.92M 5.43M 353M 5.82M 36.03M 14.18M 169M 14.65M 14.35M
Net Debt - -
More financial data * Estimated data
Logo Takara Bio Inc.
TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Employees
1,779
More about the company
Date Price Change Volume
26-01-15 826.00 ¥ -1.08% 31,800
26-01-15 835.00 ¥ +2.20% 247,300
26-01-14 817.00 ¥ +0.12% 200,100
26-01-13 816.00 ¥ -0.49% 191,400
26-01-09 820.00 ¥ -0.24% 200,400

Delayed Quote Japan Exchange, January 15, 2026 at 07:50 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
835.00JPY
Average target price
1,156.67JPY
Spread / Average Target
+38.52%
Consensus

Quarterly revenue - Rate of surprise